Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Annamycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moleculin Highlights Ph 3 AML MIRACLE Trial at Leukemia Meet
    Moleculin Highlights Ph 3 AML MIRACLE Trial at Leukemia Meet

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177430/0/en/Moleculin-to-Highlight-its-Ongoing-Phase-3-Acute-Myeloid-Leukemia-MIRACLE-Clinical-Trial-at-the-14th-Annual-Acute-Leukemia-Meeting.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Moleculin Expands Global IP With Australian Patent For Annamycin
    Moleculin Expands Global IP With Australian Patent For Annamycin

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176459/0/en/Moleculin-Expands-Global-IP-Portfolio-with-New-Australian-Patent-for-Annamycin.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Moleculin Initiates Study On Annamycin For Pancreatic Cancer
    Moleculin Initiates Study On Annamycin For Pancreatic Cancer

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171983/0/en/Moleculin-Announces-New-Investigator-Initiated-Study-of-Annamycin-for-Treating-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Moleculin Gets Canadian Patent Allowance For Annamycin
    Moleculin Gets Canadian Patent Allowance For Annamycin

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156298/0/en/Moleculin-Announces-Notice-of-Allowance-for-Canadian-Patent-Covering-Annamycin.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Moleculin Begins Phase 3 Trial in EU for Acute Myeloid Leukemia
    Moleculin Begins Phase 3 Trial in EU for Acute Myeloid Leukemia

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146083/0/en/Moleculin-Doses-First-EU-Patient-in-Phase-3-Pivotal-MIRACLE-Trial-for-Treatment-of-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Moleculin to Get New European Patent for Annamycin
    Moleculin to Get New European Patent for Annamycin

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3124080/0/en/Moleculin-Receives-Notice-of-Intent-to-Grant-New-European-Patent-for-Annamycin.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share